We are live on
!
Find out more
CG
Carlyle Group Portfolio holdings
AUM
$10.6B
1-Year Est. Return
11.25%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+11.25%
3 Year Est. Return
-0.47%
5 Year Est. Return
-4.92%
10 Year Est. Return
+7.54%
AUM
$10.6B
AUM Growth
-$2.95B
(-22%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-30.86%
Top 10 Holdings %
Top 10 Hldgs %
99.93%
Holding
21
New
1
Increased
–
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HTFL
Heartflow Inc
HTFL
|
+$555K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SARO
StandardAero Inc
SARO
|
+$2.03B |
| 2 |
MDLN
Medline Inc
MDLN
|
+$1.25B |
| 3 |
NCNA
NuCana
NCNA
|
+$480K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 78.9% |
| 2 | Industrials | 20.59% |
| 3 | Real Estate | 0.23% |
| 4 | Technology | 0.22% |
| 5 | Communication Services | 0.05% |
No holdings matched the selected filter criteria.
Similar funds
SGA
PF
BMSSC
EAM
WAM
HTC
CA
OIA
Carlyle Group's Q1 2026 Portfolio in Review
As of Q1 2026, Carlyle Group held 21 positions worth $10.6B, down 22% from $13.6B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Carlyle Group withdrew a net $3.28B in Q1 2026, closing 1 position and reducing 2 holdings. Its most notable exit was NuCana, an estimated $480K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 67% a quarter earlier, followed by Industrials and Real Estate.
Against the trend, Carlyle Group opened a new position in Heartflow Inc worth $497K.
- Carlyle Group's largest Q1 2026 buy was Heartflow Inc: 20,438 shares worth $497K.
- Carlyle Group's biggest Q1 2026 reduction was StandardAero Inc, cutting an estimated $2.03B.
- Carlyle Group fully exited NuCana in Q1 2026, selling an estimated $480K.
- Carlyle Group's ten largest holdings make up 100% of its $10.6B portfolio in Q1 2026.
- Carlyle Group opened 1 new position and closed 1 in Q1 2026.
- Carlyle Group's portfolio value fell 22% quarter-over-quarter to $10.6B.
Based on Carlyle Group's 13F filing for Q1 2026, filed 8 May 2026.